This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: The Innovative Contributions of Didier Roche in Pharmaceutical Development
Introduction: Didier Roche is a notable inventor based in Lyons, France, recognized for his valuable contributions to the field of pharmaceuticals. With a strong background in research and development, he has made a significant impact in his industry through his inventive talents.
Latest Patents: Didier Roche holds a patent for "Substituted 2-oxo-1,4-diazacycloalkanes." This innovation represents a significant advancement in pharmaceutical chemistry, showcasing his expertise in developing compounds with potential therapeutic applications.
Career Highlights: Currently, Didier Roche is associated with Novartis AG, one of the leading global healthcare companies. His work at Novartis has allowed him to push the boundaries of scientific discovery and contribute to groundbreaking solutions in medicine.
Collaborations: Throughout his career, Didier has had the opportunity to collaborate with esteemed colleagues, including Rainer Albert and Josef Gottfried Meingassner. These partnerships have enriched his work, fostering teamwork and innovation in pursuing their shared goals in pharmaceutical development.
Conclusion: Didier Roche's contributions as an inventor and researcher at Novartis AG demonstrate his commitment to advancing the field of pharmaceuticals. His patent, along with collaborative efforts, underscores the importance of innovation in improving health outcomes and showcases the crucial role inventors play in driving progress in science and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile